$2.01
-0.01-0.5%
Last update: Nov 11, 10:40 AM
Quantum BioPharma Ltd
QNTMNASDAQ
The average analyst price target for Quantum BioPharma is $8, 298.0% above the current price. The one analyst covering it rates it Buy. The latest change came on Aug 31, 2026, when Rodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating and a $8 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
